Lipids Market
Description
Lipids Market Report by Type (Omega-3 and Omega-6, Phospholipids, Medium Chain Triglycerides, Sterols), Source (Plant, Animal), Form (Powder, Liquid), Application (Dietary Supplements and Nutraceuticals, Infant Formula, Pharmaceutical, Food Fortification, Animal Nutrition, and Others), and Region 2025-2033
The global lipids market size reached USD 11.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 22.3 Billion by 2033, exhibiting a growth rate (CAGR) of 7.38% during 2025-2033. The growing demand for healthy food and supplements, along with the rising need to add sufficient nutrition to the daily diet, is bolstering the market.
Lipids Market Trends:
Increasing Demand for Nucleic Acid Delivery
Lipids play a key role in delivering nucleic acids for therapies, as they enhance stability and bioavailability in drug formulations. In contrast, the market benefits from the rising development of lipid-based delivery systems, which is essential for safely transporting genetic material into target cells. For instance, in February 2024, Evonik partnered with the University of Mainz to commercialize randomized polyethylene glycols (rPEGs) for nucleic acid delivery. These specialized lipids, part of Evonik’s expanding drug delivery platform, aim to improve immunogenicity profiles for applications such as mRNA vaccines and gene therapies.
Expanding Cardiovascular Disease Management Solutions
Lipids are key in managing cholesterol and improving patient outcomes in cardiovascular care. Moreover, the growing focus on lipid therapies and clinical solutions to reduce cardiovascular risks drives the demand for improved lipid testing, management, and treatment options within healthcare systems. For instance, in May 2024, Health Innovation South West launched a new toolkit to enhance lipid services for cardiovascular disease patients. The Somerset Lipids Project, financed by the Collaborative Lipids Fund, led to expanded clinics, reduced wait times, and improved lipid management through targeted education and service redesign.
Advancements in Lipid Testing Standardization
Standardization in lipid testing improves the accuracy of cholesterol and lipid level measurements. The demand for consistent, reliable lipid tests is growing as healthcare shifts towards precision medicine, thereby helping healthcare providers better assess risks and tailor treatments for patients, supporting market expansion. For instance, in September 2024, the Association for Diagnostics & Laboratory Medicine (ADLM) released new guidelines to standardize lipid testing for cardiovascular care. This guidance aims to improve lipid test accuracy, covering cholesterol measurements, non-HDL-C, and LDL-C, and reducing fasting requirements, thereby enhancing patient care and testing accessibility.
Global Lipids Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with the market forecast at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on type, source, form, and application.
Breakup by Type:
Omega-3 and omega-6 fatty acids are essential lipids that support heart and brain health, and phospholipids are key components of cell membranes. At the same time, medium-chain triglycerides provide rapid energy, while sterols such as cholesterol, are vital for cell structure and hormone synthesis, thereby highlighting the diverse roles of lipids.
Breakup by Source:
Plant lipids, such as those from seeds and nuts, are typically rich in unsaturated fatty acids, promoting heart health. In contrast, animal lipids, found in meats and dairy, often contain saturated fats, thereby influencing cholesterol levels and overall health profiles.
Breakup by Form:
As per the lipids market outlook, it can be sourced in both powder and liquid forms. Furthermore, powdered lipids, like certain protein supplements, offer convenience for easy incorporation into diets, while liquid lipids, such as oils provide versatile culinary uses and essential fatty acids for health.
Breakup by Application:
Lipids play a vital role in dietary supplements and nutraceuticals, enhancing health benefits and nutrient absorption. Meanwhile, in infant formulas, they provide essential fatty acids for growth, and in pharmaceuticals, lipids facilitate drug delivery. At the same time, in food fortification and animal nutrition, they improve nutritional quality and overall health.
Breakup by Region:
In the Asia Pacific region, the growing demand for healthy fats drives lipid consumption, particularly in cooking oils and supplements, and Europe emphasizes omega-3 fatty acids in health products. On the contrary, North America focuses on functional lipids for dietary enhancements, and Latin America is witnessing increased interest in natural lipid sources. Meanwhile, the Middle East and Africa are exploring lipids for both traditional cuisines and emerging health trends, thereby broadening their applications across various sectors and elevating the lipids market share.
Competitive Landscape:
The research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:
The global lipids market size reached USD 11.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 22.3 Billion by 2033, exhibiting a growth rate (CAGR) of 7.38% during 2025-2033. The growing demand for healthy food and supplements, along with the rising need to add sufficient nutrition to the daily diet, is bolstering the market.
Lipids Market Trends:
Increasing Demand for Nucleic Acid Delivery
Lipids play a key role in delivering nucleic acids for therapies, as they enhance stability and bioavailability in drug formulations. In contrast, the market benefits from the rising development of lipid-based delivery systems, which is essential for safely transporting genetic material into target cells. For instance, in February 2024, Evonik partnered with the University of Mainz to commercialize randomized polyethylene glycols (rPEGs) for nucleic acid delivery. These specialized lipids, part of Evonik’s expanding drug delivery platform, aim to improve immunogenicity profiles for applications such as mRNA vaccines and gene therapies.
Expanding Cardiovascular Disease Management Solutions
Lipids are key in managing cholesterol and improving patient outcomes in cardiovascular care. Moreover, the growing focus on lipid therapies and clinical solutions to reduce cardiovascular risks drives the demand for improved lipid testing, management, and treatment options within healthcare systems. For instance, in May 2024, Health Innovation South West launched a new toolkit to enhance lipid services for cardiovascular disease patients. The Somerset Lipids Project, financed by the Collaborative Lipids Fund, led to expanded clinics, reduced wait times, and improved lipid management through targeted education and service redesign.
Advancements in Lipid Testing Standardization
Standardization in lipid testing improves the accuracy of cholesterol and lipid level measurements. The demand for consistent, reliable lipid tests is growing as healthcare shifts towards precision medicine, thereby helping healthcare providers better assess risks and tailor treatments for patients, supporting market expansion. For instance, in September 2024, the Association for Diagnostics & Laboratory Medicine (ADLM) released new guidelines to standardize lipid testing for cardiovascular care. This guidance aims to improve lipid test accuracy, covering cholesterol measurements, non-HDL-C, and LDL-C, and reducing fasting requirements, thereby enhancing patient care and testing accessibility.
Global Lipids Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with the market forecast at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on type, source, form, and application.
Breakup by Type:
- Omega-3 and Omega-6
- Phospholipids
- Medium Chain Triglycerides
- Sterols
Omega-3 and omega-6 fatty acids are essential lipids that support heart and brain health, and phospholipids are key components of cell membranes. At the same time, medium-chain triglycerides provide rapid energy, while sterols such as cholesterol, are vital for cell structure and hormone synthesis, thereby highlighting the diverse roles of lipids.
Breakup by Source:
- Plant
- Animal
Plant lipids, such as those from seeds and nuts, are typically rich in unsaturated fatty acids, promoting heart health. In contrast, animal lipids, found in meats and dairy, often contain saturated fats, thereby influencing cholesterol levels and overall health profiles.
Breakup by Form:
- Powder
- Liquid
As per the lipids market outlook, it can be sourced in both powder and liquid forms. Furthermore, powdered lipids, like certain protein supplements, offer convenience for easy incorporation into diets, while liquid lipids, such as oils provide versatile culinary uses and essential fatty acids for health.
Breakup by Application:
- Dietary Supplements and Nutraceuticals
- Infant Formula
- Pharmaceutical
- Food Fortification
- Animal Nutrition
- Others
Lipids play a vital role in dietary supplements and nutraceuticals, enhancing health benefits and nutrient absorption. Meanwhile, in infant formulas, they provide essential fatty acids for growth, and in pharmaceuticals, lipids facilitate drug delivery. At the same time, in food fortification and animal nutrition, they improve nutritional quality and overall health.
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
In the Asia Pacific region, the growing demand for healthy fats drives lipid consumption, particularly in cooking oils and supplements, and Europe emphasizes omega-3 fatty acids in health products. On the contrary, North America focuses on functional lipids for dietary enhancements, and Latin America is witnessing increased interest in natural lipid sources. Meanwhile, the Middle East and Africa are exploring lipids for both traditional cuisines and emerging health trends, thereby broadening their applications across various sectors and elevating the lipids market share.
Competitive Landscape:
The research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:
- Archer Daniels Midland Company
- BASF SE
- Cargill Incorporated
- Clover Corporation Limited
- Croda International Plc
- FrieslandCampina Ingredients
- Kerry Group plc
- Koninklijke DSM N.V.
- Nordic Naturals Inc.
- Omega Protein Corporation (Cooke Inc.)
- Polaris
- How has the global lipids market performed so far, and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global lipids market growth?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the source?
- What is the breakup of the market based on the form?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global lipids market, and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
147 Pages
- 1 Preface
- 2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
- 3 Executive Summary
- 4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
- 5 Global Lipids Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
- 6 Market Breakup by Type
- 6.1 Omega-3 and Omega-6
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Phospholipids
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Medium Chain Triglycerides
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Sterols
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 7 Market Breakup by Source
- 7.1 Plant
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Animal
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 8 Market Breakup by Form
- 8.1 Powder
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Liquid
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 9 Market Breakup by Application
- 9.1 Dietary Supplements and Nutraceuticals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Infant Formula
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Pharmaceutical
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Food Fortification
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Animal Nutrition
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
- 9.6 Others
- 9.6.1 Market Trends
- 9.6.2 Market Forecast
- 10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
- 11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
- 12 Value Chain Analysis
- 13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
- 14 Price Analysis
- 15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Archer Daniels Midland Company
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 BASF SE
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Cargill Incorporated
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 SWOT Analysis
- 15.3.4 Clover Corporation Limited
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.5 Croda International Plc
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 FrieslandCampina Ingredients
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Kerry Group plc
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.8 Koninklijke DSM N.V.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Nordic Naturals Inc.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Omega Protein Corporation (Cooke Inc.)
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.11 Polaris
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.